These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1158013)

  • 1. 'Isopathic phenomenon' in leprosy.
    Rao BN; Satyanarayana BV; Venkatarathnam G; Reddy CR
    Dermatologica; 1975; 150(3):169-75. PubMed ID: 1158013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does isopathic phenomenon occur in leprosy?
    Lal S; Natarajan S; Veliath AJ; Garg BR
    Lepr India; 1983 Jul; 55(3):495-9. PubMed ID: 6656207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro immunologic changes in 6 lepromatous leprosy or borderline leprosy patients treated with BCG alone or BCG and lepromin for 12 to 20 months, followed by BCG and antibiochemotherapy for 1 to 2 years].
    Saint-André P; Ferracci C; Baquillon G; Travi Piacentile M
    Acta Leprol; 1979; (76-77):311-4. PubMed ID: 121851
    [No Abstract]   [Full Text] [Related]  

  • 6. Isopathic phenomenon in lepromatous leprosy. A reappraisal.
    Job CK
    Int J Lepr Other Mycobact Dis; 1969; 37(4):365-71. PubMed ID: 5394257
    [No Abstract]   [Full Text] [Related]  

  • 7. A re-evaluation of tissue reactivity to BCG, tuberculin and ink in lepromatous leprosy. Absence of isopathic phenomenon.
    KOOIJ R; PEPLER WJ
    Dermatologica; 1961 May; 122():360-72. PubMed ID: 13753037
    [No Abstract]   [Full Text] [Related]  

  • 8. Histology of the Fernandez reaction. An appraisal.
    Thomas J; Joseph M; Ramanujam K; Chacko CJ; Job CK
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):1-8. PubMed ID: 7195878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy.
    Rea TH; Modlin RL
    Immunol Ser; 1989; 46():723-45. PubMed ID: 2488876
    [No Abstract]   [Full Text] [Related]  

  • 10. Borderline tuberculoid leprosy following BCG vaccination. A case report.
    Stoner GL; Belehu A; Nsibambi J; Warndorff J
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):16-20. PubMed ID: 7195879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to Sagher on the "Isopathic phenomenon" in lepromatous leprosy.
    KOOIJ R; PEPLER WJ
    Dermatologica; 1963; 126():268-70. PubMed ID: 14034668
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
    Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
    Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue response to lepromin, an index of susceptibility of the armadillo to M. leprae infection--a preliminary report.
    Job CK; Kirchheimer WF; Sanchez RM
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):177-82. PubMed ID: 6749706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG.
    Meyers WM; McDougall AC; Fleury RN; Neves R; Reyes O; Binford CH
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):302-9. PubMed ID: 3045226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Eruptions in the course of immunologic reversions in lepromatous patients treated with immunomodulating agents].
    Saint-André P; Baquillon G
    Acta Leprol; 1986; 4(2):201-3. PubMed ID: 3551456
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement in the histological diagnosis of indeterminate leprosy by demonstration of mycobacterial antigens.
    Natrajan M; Katoch K; Katoch VM; Bharadwaj VP
    Acta Leprol; 1995; 9(4):201-7. PubMed ID: 8711981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Kveim test in leprosy.
    Krishnamurthy S; Verghese R; Job CK
    Int J Lepr Other Mycobact Dis; 1975; 43(4):333-8. PubMed ID: 1241690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration.
    Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuritic leprosy: further progression and significance.
    Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya GN; Girdhar BK
    Acta Leprol; 1995; 9(4):187-94. PubMed ID: 8711979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.